ANDA 87022, held by Lannett. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 87022 (Phentermine Hydrochloride), held by Lannett, was first approved by FDA on Feb 3, 1983, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 3, 1983 | Original application | Approved | None posted |
| Phentermine Hydrochloride30MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| Phentermine Hydrochloride15MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 21Labeling · Standard review | Approved | None posted |
| Mar 14, 2013 | Supplement 15Manufacturing | Approved | None posted |
| Dec 5, 2012 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 19, 2012 | Supplement 12Labeling | Approved | None posted |
| Apr 19, 2012 | Supplement 13Labeling | Approved | None posted |
| Jan 20, 2012 | Supplement 9Manufacturing | Approved | None posted |
| Aug 27, 2010 | Supplement 11Labeling | Approved | None posted |
| Jun 28, 2010 | Supplement 10Labeling | Approved | None posted |
| Dec 6, 2007 | Supplement 4Labeling | Approved | None posted |
| Feb 3, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters